TABLE 2.
Prevalence and univariate associations between M. genitalium infection and other STIs
| STI | NAAT prevalence, % (no. positive/no. tested) | No. (%) of samples with result |
Odds ratio (95% CI) | P valuea | |
|---|---|---|---|---|---|
| M. genitalium positive | M. genitalium negative | ||||
| M. genitalium | 1.5 (7/473) | NAe | NA | NA | NA |
| C. trachomatis | 2.1 (10/473) | 0 (0.0) | 10 (2.1) | 2.9 (0.2–54.2) | 1.00 |
| N. gonorrhoeae | 0.6 (3/473) | 1 (14.3) | 2 (0.4) | 38.7 (3.1–486.6) | 0.04 |
| T. vaginalis | 4.4 (21/473) | 1 (14.3) | 20 (4.3) | 3.7 (0.04–32.4) | 0.27 |
| High-risk HPVb,c | 32 (111/347) | 3 (60.0) | 108 (31.6) | 3.2 (0.5–19.7) | 0.33 |
| HPV16c | 5.2 (18/347) | 0 (0.0) | 18 (5.3) | 1.6 (0.1–30.0) | 1.00 |
| HPV18c | 3.5 (12/347) | 2 (40.0) | 10 (2.9) | 22.1 (3.3–147.5) | 0.01 |
| OHR HPV typesc,d | 28.8 (100/347) | 2 (40.0) | 98 (28.7) | 1.6 (0.3–10.0) | 0.63 |
a
Fisher's exact test.
b
Combined HPV results for 14 high-risk HPV types (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68).
c
HPV results were available for 347 subjects.
d
OHR, combination result for 12 other high-risk HPV types (31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68).
e
NA, not applicable.